LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.93 | 27.76 | 3975 | 4421 | 0.8990 | 0.9711 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.93 | 27.76 | 5673 | 4421 | 1.2831 | 1.0693 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 47.93 | 27.76 | 5733 | 4421 | 1.2966 | 1.0723 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 49.63 | 27.76 | 4208 | 4818 | 0.8734 | 0.9639 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 49.63 | 27.76 | 4254 | 4818 | 0.8829 | 0.9668 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 49.63 | 27.76 | 6026 | 4818 | 1.2507 | 1.0611 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 49.63 | 27.76 | 6092 | 4818 | 1.2644 | 1.0641 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 51.33 | 27.76 | 4453 | 5117 | 0.8702 | 0.9634 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 51.33 | 27.76 | 4507 | 5117 | 0.8808 | 0.9666 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 51.33 | 27.76 | 6347 | 5117 | 1.2404 | 1.0581 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 51.33 | 27.76 | 6395 | 5117 | 1.2497 | 1.0601 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.04 | 27.76 | 4711 | 5365 | 0.8780 | 0.9660 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.04 | 27.76 | 4782 | 5365 | 0.8912 | 0.9699 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.04 | 27.76 | 6690 | 5365 | 1.2468 | 1.0589 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 53.04 | 27.76 | 6758 | 5365 | 1.2595 | 1.0617 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 54.74 | 27.76 | 4955 | 5606 | 0.8838 | 0.9680 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 54.74 | 27.76 | 5037 | 5606 | 0.8984 | 0.9722 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 54.74 | 27.76 | 6938 | 5606 | 1.2375 | 1.0564 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 54.74 | 27.76 | 7019 | 5606 | 1.2519 | 1.0595 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 56.45 | 27.76 | 5193 | 5745 | 0.9039 | 0.9739 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 56.45 | 27.76 | 5250 | 5745 | 0.9138 | 0.9767 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 56.45 | 27.76 | 7236 | 5745 | 1.2594 | 1.0609 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 56.45 | 27.76 | 7351 | 5745 | 1.2795 | 1.0651 | MN20160318_Q01 | J07 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.15 | 27.76 | 5451 | 5906 | 0.9229 | 0.9794 | MN20160318_Q01 | E09 |
MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 58.15 | 27.76 | 5527 | 5906 | 0.9357 | 0.9829 | MN20160318_Q01 | E09 |